206640.KQ KOE
Boditech Med Inc.
1W: +4.3%
1M: -3.3%
3M: -7.8%
YTD: -26.1%
1Y: -30.3%
3Y: -33.4%
5Y: -54.9%
₩9,750.00 ($7.26)
+50.00 (+0.52%)
Weekly Expected Move ±2.4%
₩9276
₩9513
₩9750
₩9987
₩10224
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$24.9B
-27.5% ▼
5Y CAGR: +7.6%
Capital Expenditures
$12.5B
-121.4% ▼
5Y CAGR: +19.7%
Free Cash Flow
$12.4B
-56.7% ▼
5Y CAGR: +0.4%
Dividends Paid
$4.4B
-33.4% ▼
Buybacks
$3.0B
+0.0% ▲
Net Change in Cash
$5.5B
-66.4% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $45.5B | $44.4B | $24.2B | $25.9B | $27.2B |
| Depreciation & Amort. | $5.4B | $6.0B | $7.5B | $8.2B | $8.4B |
| Stock-Based Comp. | -$22M | $57M | $110M | $222M | -$66M |
| Change in Working Capital | -$24.5B | -$5.2B | -$4.8B | -$6.2B | -$8.3B |
| Other Non-Cash Items | -$13.9B | $306M | -$2.4B | $6.1B | -$2.4B |
| Operating Cash Flow | $44.6B | $49.9B | $23.1B | $34.3B | $24.9B |
| — Investing Activities — | |||||
| Capital Expenditures | -$4.3B | -$18.4B | -$16.9B | -$5.6B | -$11.4B |
| Acquisitions (Net) | $260M | -$187M | $313M | $182M | $1.0B |
| Investment Purchases | -$37.8B | -$69.0B | -$20.5B | -$31.6B | -$18.3B |
| Investment Sales | $1.7B | $71.2B | $12.9B | $20.7B | $16.4B |
| Other Investing | $200M | $406M | -$270M | $270M | $340M |
| Investing Cash Flow | -$40.0B | -$16.0B | -$24.5B | -$16.1B | -$12.0B |
| — Financing Activities — | |||||
| Net Debt Issuance | -$3.8B | -$5.4B | $2.2B | $1.1B | -$763M |
| Stock Repurchased | $0 | -$8.8B | -$7.2B | $0 | -$3.0B |
| Dividends Paid | -$1.1B | -$4.6B | -$4.3B | -$3.3B | -$4.4B |
| Other Financing | -$649M | -$842M | -$887M | $212M | $11M |
| Financing Cash Flow | -$4.1B | -$19.6B | -$10.2B | -$1.9B | -$8.0B |
| Net Change in Cash | $225M | $14.8B | -$12.6B | $16.2B | $5.5B |
| Cash End of Period | $24.0B | $38.8B | $26.3B | $42.5B | $47.9B |
| Free Cash Flow | $40.4B | $31.5B | $6.2B | $28.7B | $12.4B |